Advertisement
LEXX vs MDXG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEXX is a StrongBuy and MDXG is a Hold.
LEXX in upward trend: price may jump up because it broke its lower Bollinger Band on October 02, 2026
LEXX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 26 cases where LEXX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for LEXX just turned positive on September 23, 2026. Looking at past instances where LEXX's MACD turned positive, the stock continued to rise in 39 of 45 cases over the following month. The odds of a continued upward trend are 87%.
Following a +11.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where LEXX advanced for three days, in 238 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LEXX as a result. In 77 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The 50-day moving average for LEXX moved below the 200-day moving average on October 08, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LEXX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for LEXX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.311) is normal, around the industry mean (2.973). P/E Ratio (-0.578) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (23.310) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. LEXX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LEXX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
MDXG in downward trend: 10-day moving average crossed below 50-day moving average on October 21, 2026
The 10-day moving average for MDXG crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDXG as a result. In 83 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for MDXG turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 28 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
MDXG moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for MDXG entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for MDXG moved above the 200-day moving average on October 06, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +4.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDXG advanced for three days, in 196 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
MDXG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. MDXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.655) is normal, around the industry mean (2.973). MDXG has a moderately high P/E Ratio (78.600) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (1.985) is also within normal values, averaging (438.009).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
LEXX | MDXG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 74 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 88 | |
PRICE GROWTH RATING 1..100 | 93 | 64 | |
P/E GROWTH RATING 1..100 | 100 | 4 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LEXX's Valuation (60) in the null industry is somewhat better than the same rating for MDXG (96) in the Biotechnology industry. This means that LEXX’s stock grew somewhat faster than MDXG’s over the last 12 months.
LEXX's Profit vs Risk Rating (100) in the null industry is in the same range as MDXG (100) in the Biotechnology industry. This means that LEXX’s stock grew similarly to MDXG’s over the last 12 months.
MDXG's SMR Rating (88) in the Biotechnology industry is in the same range as LEXX (99) in the null industry. This means that MDXG’s stock grew similarly to LEXX’s over the last 12 months.
MDXG's Price Growth Rating (64) in the Biotechnology industry is in the same range as LEXX (93) in the null industry. This means that MDXG’s stock grew similarly to LEXX’s over the last 12 months.
MDXG's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for LEXX (100) in the null industry. This means that MDXG’s stock grew significantly faster than LEXX’s over the last 12 months.
| LEXX | MDXG | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 69% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 78% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 78% |
| TrendMonth ODDS (%) | 1 day ago 85% | 1 day ago 81% |
| Advances ODDS (%) | 1 day ago 85% | 11 days ago 74% |
| Declines ODDS (%) | 4 days ago 86% | 2 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 84% | 1 day ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LEXX’s FA Score shows that 0 FA rating(s) are green while MDXG’s FA Score has 1 green FA rating(s).
- LEXX’s FA Score: 0 green, 5 red.
- MDXG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LEXX’s TA Score shows that 4 TA indicator(s) are bullish while MDXG’s TA Score has 5 bullish TA indicator(s).
- LEXX’s TA Score: 4 bullish, 4 bearish.
- MDXG’s TA Score: 5 bullish, 6 bearish.
Price Growth
LEXX (@Biotechnology) experienced а -1.34% price change this week, while MDXG (@Biotechnology) price change was -16.03% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
LEXX is expected to report earnings on Nov 25, 2026.
MDXG is expected to report earnings on Oct 28, 2026.
Industries' Descriptions
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
LEXX and
Correlation & Price change
A.I.dvisor tells us that LEXX and ASMB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and ASMB's prices will move in lockstep.
| Ticker / NAME | Correlation To LEXX | 1D Price Change % | ||
|---|---|---|---|---|
| LEXX | 100% | +4.61% | ||
| ASMB - LEXX | 29% Poorly correlated | -0.88% | ||
| MIST - LEXX | 28% Poorly correlated | +1.06% | ||
| NRSN - LEXX | 27% Poorly correlated | -4.69% | ||
| EPRX - LEXX | 27% Poorly correlated | -1.81% | ||
| MDXG - LEXX | 26% Poorly correlated | +5.08% | ||
More | ||||
MDXG and
Correlation & Price change
A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To MDXG | 1D Price Change % | ||
|---|---|---|---|---|
| MDXG | 100% | +5.08% | ||
| AXON - MDXG | 47% Loosely correlated | +2.98% | ||
| VCYT - MDXG | 42% Loosely correlated | -0.39% | ||
| ARRY - MDXG | 39% Loosely correlated | -3.23% | ||
| INM - MDXG | 38% Loosely correlated | -3.62% | ||
| TAOX - MDXG | 34% Loosely correlated | -5.50% | ||
More | ||||